BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Up 433.3% in May

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a significant growth in short interest in May. As of May 15th, there was short interest totaling 46,393 shares, a growth of 433.3% from the April 30th total of 8,700 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 3,299 shares, the short-interest ratio is currently 14.1 days.

BioNxt Solutions Price Performance

Shares of OTCMKTS:BNXTF remained flat at $0.31 during midday trading on Friday. 427 shares of the stock were exchanged, compared to its average volume of 1,490. The business has a 50 day moving average price of $0.35 and a 200 day moving average price of $0.42. The stock has a market cap of $37.41 million, a price-to-earnings ratio of -7.64 and a beta of 0.69. BioNxt Solutions has a one year low of $0.14 and a one year high of $0.80.

BioNxt Solutions (OTCMKTS:BNXTF) last released its quarterly earnings data on Wednesday, April 29th. The company reported ($0.01) EPS for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.